HNGEHinge Health, Inc.

$102.86+81% 1Y
Latest close: a new 52-week highOct 9, 2026what changed →

Is the business good?

Mixed

The checks split: nothing decisive, though earnings fully cash-backed (3.2×).

1 good, 1 neutral, 2 without data
Fundamental health (F-score)4 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash3.16×derived · Jun 30, 2026

Operating profit is fully backed by cash.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversiontop 6% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is HNGE?

Hinge Health, Inc. keeps 13% of every revenue dollar as operating profit, against 2.8% for the median Health Information Services name.

13%

Operating margin · Health Information Services median 2.8% · 12 months to Q2 2026

Cash conversion
3.16×

Cash conversion · operating cash flow covers the operating profit after tax

Share count, year on year
+90%

Share count, year on year · shareholders own a smaller slice than a year ago

R&D as % of revenue
18%

R&D as % of revenue

Operating margin by fiscal year
YearOperating margin
FY2023−45%
FY2024−8.2%
FY2025−93%
Details›
Gross margin12 months to Q2 2026
84%
Operating margin12 months to Q2 2026
13%
Net margin12 months to Q2 2026
15%
Free cash flow margin
40%
R&D as % of revenue
18%
Revenue, trailing twelve months
$720M
Free cash flow, trailing twelve months
$290M
Net income, trailing twelve months
$109M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.